5
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats

, , , , &
Pages 81-88 | Published online: 08 Jul 2009

REFERENCES

  • Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1982; 19: 410–15.
  • Zatz R, Meyer TW, Anderson S, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Nat Acad Sci USA 1985; 82: 5963–7.
  • Yaun BH, Robinette JB, Conger JD. Effect of angiotensin II and norepinephrine on isolated rat afferent arterioles. Am J Physiol 1990; 258: F741—F750.
  • Erman A, van Dyk DJ, Chen-Gal B, Iskera D, Giler S, Rosenfeld JB, Boner G. Angiotensin converting enzyme activity in the serum, lung and kidney of diabetic rats. Eur J Clin Invest 1993; 23: 615–20.
  • Valentovic MA, Elliott CW, Ball JG. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme acti-vity. Res Commun Chem Pathol Pharmacol 1987; 58: 27–38.
  • Anderson S, Jung FF, Ingelfinger JR. Renal renin—angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol 1993; 265: F477—F486.
  • van Dyk DJ, Erman A, Erman T, Chen-Gal B, Sulkes J, Boner G. Increased serum angiotensin converting enzyme activity in type I diabetic patients. Eur J Chin Invest 1994; 24: 463–7.
  • Erman A, Chen-Gal B, Zabludowski J, Rosen-feld JB. Cyclosporine A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J Pharm Pharmacol 1990; 42: 425–7.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin reagent. J Chem Biol 1951; 193: 265–75.
  • Bradford AA. A rapid and sensitive method for the quatitation of microgram quantities of protein utilizing the principle of dye binding. Ann Biochem 1976; 72: 248–54.
  • Christlieb AR, Long R, Underwood RH. Renin—angiotensin—aldosterone system, electro-lyte homeostasis and blood pressure in alloxan diabetes. Am J Med Sci 1979; 277: 295–303.
  • Christlieb AR. Renin, angiotensin, and norepine-phrine in alloxan diabetes. Diabetes 1974; 23: 962–70.
  • Flordal PR. The plasma dilution factor: Predict-ing how concentrations in plasma and serum are affected by blood volume variations and blood loss. J Lab Clin Med 1995; 126: 353–7.
  • Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990; 16: 363–70.
  • Correa-Rotter R, Hostetter TH, Rosenberg ME. Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int 1992; 41: 796–804.
  • Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986; 77: 1925–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.